Project Details
Description
Feasibility Study Of An IL-2 Expressing, Attenuated Salmonella Typhimurium In Patients With Resectable Hepatic Primary Tumor or Hepatic Spread From Any Non-Hematologic Primary
Status | Finished |
---|---|
Effective start/end date | 8/1/13 → 6/30/14 |
Funding
- COURANTE ONCOLOGY, LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.